Product Profiles

Article

A round-up of the latest ophthalmic products

Continuous IOP monitoring

Patients can wear the lens for up to 24 hours and can perform every day activities, including sleeping. An adhesive antennae is worn around the eye and is connected to a portable recording device.

Please visit http://www.sensimed.com/ for more information

Dual OVD pack

The Healon cohesive and Healon EndoCoat dispersive OVDs are used in cataract extraction and IOL implantation.

Healon EndoCoat OVD is injected into the eye to protect and coat the eye during surgery, enabling surgical clarity and reducing trauma to the inside layer of the cornea and surrounding tissues. Healon OVD provides high viscosity to maintain space in the posterior chamber of the eye and helps to facilitate IOL implantation after cataract removal.

For further information please go to http://www.abbott.com/

Blepharitis treatment range

Featuring a BlephaMask, a reusable eye mask that holds temperature for up to 10 minutes, the kit also features a temperature indicator that informs patients when the mask is the right temperature. With both the BlephaMask and the BlephaCura liposomal suspension the meibomian glands are cleared, debris is removed from the lid margins and bacterial count is reduced.

Please go to http://www.altacoreyeproducts.com/ for more details.

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.